Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day ...
One way to think about NAD+ is as an energy courier. It shuttles electrons to the mitochondria, where ATP is produced. When ...
Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval.
A recent study highlights a cheaper and more efficient method to produce the artificial sweetener tagatose. However, does ...
Many claim the latest viral ingredient is as good as filler. Experts weigh in on the truth (and now to use the product in your rourtine).
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Passed down for centuries, this cure-all drink is having a moment.
Diet and prebiotic sodas are low-sugar alternatives to regular soda that both affect your blood sugar levels differently. Nutrition experts say that both options can help people cut back on added ...
The Journal of Head and Face Pain, researchers at University of California San Diego School of Medicine demonstrate for the first time in a placebo-controlled clinical trial that cannabis is effective ...
The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast ...
The EMA’s positive opinion on Kygevvi marks a turning point for patients with TK2d, an ultra-rare genetic muscle disease previously managed only with supportive care.
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results